367 related articles for article (PubMed ID: 25234962)
1. Adjuvants for foot-and-mouth disease virus vaccines: recent progress.
Cao Y
Expert Rev Vaccines; 2014 Nov; 13(11):1377-85. PubMed ID: 25234962
[TBL] [Abstract][Full Text] [Related]
2. CpG oligodeoxynucleotide and montanide ISA 206 adjuvant combination augments the immune responses of a recombinant FMDV vaccine in cattle.
Ren J; Yang L; Xu H; Zhang Y; Wan M; Liu G; Zhao L; Wang L; Yu Y
Vaccine; 2011 Oct; 29(45):7960-5. PubMed ID: 21872635
[TBL] [Abstract][Full Text] [Related]
3. Rational design and efficacy of a multi-epitope recombinant protein vaccine against foot-and-mouth disease virus serotype A in pigs.
Cao Y; Li D; Fu Y; Bai Q; Chen Y; Bai X; Jing Z; Sun P; Bao H; Li P; Zhang J; Ma X; Lu Z; Liu Z
Antiviral Res; 2017 Apr; 140():133-141. PubMed ID: 28161579
[TBL] [Abstract][Full Text] [Related]
4. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice.
Borrego B; Rodríguez-Pulido M; Mateos F; de la Losa N; Sobrino F; Sáiz M
Vaccine; 2013 Sep; 31(40):4375-81. PubMed ID: 23859841
[TBL] [Abstract][Full Text] [Related]
5. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of virus like particle (VLP) vaccine of foot-and-mouth-disease virus (FMDV) type O adjuvanted with poly I:C or CpG in guinea pigs.
Terhuja M; Saravanan P; Tamilselvan RP
Biologicals; 2015 Nov; 43(6):437-43. PubMed ID: 26493006
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of DNA vaccine (P12A3C-pcDNA) efficacy against foot-and-mouth disease by coadministration of interleukin-18-expressing (IL18 pcDNA) plasmid in guinea-pigs.
Siva Reddy K; Muralidhar Rao D; Badrinaryana N; Suryanaryana VV; Reddy GR
FEMS Immunol Med Microbiol; 2010 Dec; 60(3):261-9. PubMed ID: 21039923
[TBL] [Abstract][Full Text] [Related]
8. Poly(I:C) combined with multi-epitope protein vaccine completely protects against virulent foot-and-mouth disease virus challenge in pigs.
Cao Y; Lu Z; Li Y; Sun P; Li D; Li P; Bai X; Fu Y; Bao H; Zhou C; Xie B; Chen Y; Liu Z
Antiviral Res; 2013 Feb; 97(2):145-53. PubMed ID: 23219974
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccine (P1-2A-3C-pCDNA) co-administered with Bovine IL-18 gives protective immune response against Foot and Mouth Disease in cattle.
Kotla S; Sanghratna Vishanath B; H J D; K G; V V S S; Reddy GR
Vet Microbiol; 2016 Sep; 193():106-15. PubMed ID: 27599937
[TBL] [Abstract][Full Text] [Related]
10. Protective immune response to liposome adjuvanted high potency foot-and-mouth disease vaccine in Indian cattle.
Saravanan P; Sreenivasa BP; Selvan RP; Basagoudanavar SH; Hosamani M; Reddy ND; Nathanielsz J; Derozier C; Venkataramanan R
Vaccine; 2015 Jan; 33(5):670-7. PubMed ID: 25528522
[TBL] [Abstract][Full Text] [Related]
11. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
Dar P; Kalaivanan R; Sied N; Mamo B; Kishore S; Suryanarayana VV; Kondabattula G
Vaccine; 2013 Jul; 31(33):3327-32. PubMed ID: 23735678
[TBL] [Abstract][Full Text] [Related]
12. Enhanced efficacy of a multi-epitope vaccine for type A and O foot‑and-mouth disease virus by fusing multiple epitopes with Mycobacterium tuberculosis heparin-binding hemagglutinin (HBHA), a novel TLR4 agonist.
Lei Y; Shao J; Ma F; Lei C; Chang H; Zhang Y
Mol Immunol; 2020 May; 121():118-126. PubMed ID: 32199211
[TBL] [Abstract][Full Text] [Related]
13. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
Quattrocchi V; Bianco V; Fondevila N; Pappalardo S; Sadir A; Zamorano P
Dev Biol (Basel); 2004; 119():481-97. PubMed ID: 15742663
[TBL] [Abstract][Full Text] [Related]
14. Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.
Blignaut B; Visser N; Theron J; Rieder E; Maree FF
J Gen Virol; 2011 Apr; 92(Pt 4):849-59. PubMed ID: 21177923
[TBL] [Abstract][Full Text] [Related]
15. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
[TBL] [Abstract][Full Text] [Related]
16. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
Rodriguez LL; Gay CG
Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
[TBL] [Abstract][Full Text] [Related]
17. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
18. Development of Protective Immunity against Inactivated Iranian Isolate of Foot-and-Mouth Disease Virus Type O/IRN/2007 Using Gamma Ray-Irradiated Vaccine on BALB/c Mice and Guinea Pigs.
Motamedi-Sedeh F; Soleimanjahi H; Jalilian AR; Mahravani H; Shafaee K; Sotoodeh M; Taherkarami H; Jairani F
Intervirology; 2015; 58(3):190-6. PubMed ID: 26202581
[TBL] [Abstract][Full Text] [Related]
19. Immune enhancing effects of recombinant bovine IL-18 on foot-and-mouth disease vaccination in mice model.
Shi XJ; Wang B; Wang M
Vaccine; 2007 Jan; 25(7):1257-64. PubMed ID: 17084491
[TBL] [Abstract][Full Text] [Related]
20. Global Foot-and-Mouth Disease Research Update and Gap Analysis: 3 - Vaccines.
Robinson L; Knight-Jones TJ; Charleston B; Rodriguez LL; Gay CG; Sumption KJ; Vosloo W
Transbound Emerg Dis; 2016 Jun; 63 Suppl 1():30-41. PubMed ID: 27320164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
